Asta

246720 · KOSDAQ · ₩246720 · 아스타

₩6,070 ₩0 (0.00%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −28.08%
Market cap
₩99B
Enterprise value
₩91B
P/E
—
P/B
5.7×
Dividend yield
0.0%
ROE
−14.4%
Net margin
−72.5%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−45.2% from the high

₩5,900Today: ₩6,070 – ₩6,070₩11,080

Returns

  • 1W0.0%
  • 1M0.0%
  • 3M0.0%
  • 6M0.0%
  • YTD−26.6%
  • 1Y−28.1%
Volume today
—
Traded today
—
Listed shares
16,381,300
EPS (12 months)
−₩153
Earnings yield −2.5%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

Signals

43Quiet
  • BuzzQuietBuzz 43 of 100 (50 is a normal day for this stock).
  • MomentumFlat0% over the last month; the price is below its 20-day average.
  • News impactHigh4 news items and filings in two weeks; 1 rated high impact, 0 medium.

Signals describe activity, not recommendations. Not financial advice.

Asta stock overview

Asta (아스타, KRX: 246720) is listed on KOSDAQ, in the Biotech & Pharma sector. The company develops, manufactures and sells MALDI-TOF mass spectrometry instruments and related consumables, founded in 2006 and listed as a technology-based firm. Its shares closed at ₩6,070 on Oct 27, 2026, unchanged on the day, giving it a market value of ₩99B.

Key facts

Market cap
₩99B
Sector
Biotech & Pharma
Latest price change
0.00%
As of
Oct 27, 2026
Main business
The company develops, manufactures and sells MALDI-TOF mass spectrometry instruments and related consumables, founded in 2006 and listed as a technology-based firm.

Quick answers about Asta

What does Asta do?
The company develops, manufactures and sells MALDI-TOF mass spectrometry instruments and related consumables, founded in 2006 and listed as a technology-based firm. Its medical products, including the MicroIDsys LT, Elite and Cyclone models for microbial identification, serve hospitals, testing centers and clinics, supported by a large bacteria database and cloud-based services. It also sells LDI-TOF instruments for industrial quality control in the display, secondary battery and semiconductor industries, and is expanding into overseas markets such as the Middle East, North Africa, Europe and Taiwan, with technology licensing as a new revenue stream.
What is the market cap of Asta?
The market capitalisation of Asta was ₩99B at the close on Oct 27, 2026.
Who are the largest shareholders of Asta?
According to the latest official filings, the largest reported holders are Jo Eung-jun (31.97%, as of Oct 23, 2026); Kim Yang-seon (15.43%, as of May 15, 2025); SD Biosensor (7.33%, as of Oct 20, 2026).
When is the next earnings report from Asta?
Korean companies rarely announce results dates in advance. Based on when Asta filed the same report in past years, its next 3q results is expected around Nov 14, 2026.

Company profile

The company develops, manufactures and sells MALDI-TOF mass spectrometry instruments and related consumables, founded in 2006 and listed as a technology-based firm. Its medical products, including the MicroIDsys LT, Elite and Cyclone models for microbial identification, serve hospitals, testing centers and clinics, supported by a large bacteria database and cloud-based services. It also sells LDI-TOF instruments for industrial quality control in the display, secondary battery and semiconductor industries, and is expanding into overseas markets such as the Middle East, North Africa, Europe and Taiwan, with technology licensing as a new revenue stream.

Written by AI from the company's latest annual report.

Korean name
아스타
CEO
조응준
Founded
Jan 2006
Listed
Mar 2017
Listed shares
16,381,300
Fiscal year ends
Month 12

Similar companies

Recent news

News · Edaily·

International St. Mary's Hospital pursues digital healthcare and AI cooperation with Astana, Kazakhstan

Predicted impact: Low· Actual: −6.6% vs sector (5 trading days)

Hospital cooperation memorandum with a Kazakh city; small and no financial size given.

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Asta / 아스타 / 246720 / KRX:246720

Source: KRX statistical information